Altium Capital Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-76,000
Closed -$3.01M 114
2022
Q4
$3.01M Buy
76,000
+12,000
+19% +$499K 1.53% 26
2022
Q3
$2.98M Sell
64,000
-25,000
-28% -$1.16M 1.09% 38
2022
Q2
$3.9M Buy
89,000
+12,000
+16% +$660K 1.56% 20
2022
Q1
$5.57M Buy
77,000
+35,000
+83% +$2.52M 1.86% 14
2021
Q4
$3.4M Sell
42,000
-9,000
-18% -$902K 0.94% 42
2021
Q3
$5.93M Buy
51,000
+24,100
+90% +$3.15M 1.56% 16
2021
Q2
$4.46M Sell
26,900
-11,000
-29% -$1.72M 1.03% 33
2021
Q1
$5.29M Buy
+37,900
New +$6.18M 1.47% 19

Other funds holding NVRO

Altium Capital Management's NVRO Position: Q1 2023 in Review

Altium Capital Management sold out of NEVRO CORP. (NVRO) in Q1 2023, closing a stake of 76,000 shares — an estimated $3.01M sold.

Altium Capital Management first reported a position in NVRO in Q1 2021 and held it in 8 quarters. The position peaked at $5.93M in Q3 2021. 158 funds tracked by Wall St. Rank hold NVRO as of Q1 2023.

  • Altium Capital Management reported no remaining NEVRO CORP. position as of Q1 2023 after selling out during the quarter.
  • Altium Capital Management sold 76,000 NEVRO CORP. shares in Q1 2023, an estimated $3.01M.
  • Altium Capital Management first reported a position in NEVRO CORP. in Q1 2021 and held it in 8 quarters.
  • Altium Capital Management's NEVRO CORP. position peaked at $5.93M in Q3 2021.
  • 158 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2023.

Based on Altium Capital Management's 13F filing for Q1 2023, filed 15 May 2023.